Screener
SELLAS Life Sciences Group, Inc. SLS Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001390478-26-000008
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $3,633 | $2,948 |
| Accrued expenses and other current liabilities | 2,261 | 3,525 |
| Operating lease liabilities | 562 | 544 |
| Total current liabilities | 6,456 | 7,017 |
| Operating lease liabilities, non-current | 309 | 457 |
| Total liabilities | 6,765 | 7,474 |
| Commitments and contingencies (Note 5) | ||
| Stockholders’ equity: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is SELLAS Life Sciences Group, Inc.'s total current liabilities?
- SELLAS Life Sciences Group, Inc. (SLS) reported total current liabilities of $6.46M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s total current liabilities changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s total current liabilities decreased by 6.3% year-over-year, from $6.89M to $6.46M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s total current liabilities has grown at a -10.7% compound annual growth rate (CAGR), from $12.34M to $7.02M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about SELLAS Life Sciences Group, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude